Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a global leader in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip replacements, as well as other surgical and dental products. Zimmer Biomet competes with other major players in the medical device industry, such as Stryker Corporation and Johnson & Johnson.On November 5, 2025, Rick Wise from Stifel Nicolaus set a price target of $110 for ZBH. At that time, the stock was trading a ...